Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments).
- Author:
Yan-Ming XIE
1
;
Yu-Bin ZHAO
1
;
Jun-Jie JIANG
1
;
Yan-Peng CHANG
1
;
Wen ZHANG
1
;
Hao SHEN
1
;
Peng-Fei LU
1
Author Information
- Publication Type:Journal Article
- MeSH: Consensus; Drug Hypersensitivity; etiology; immunology; Drug Monitoring; adverse effects; methods; standards; Drugs, Chinese Herbal; adverse effects; Expert Testimony; Humans; Immunologic Techniques; methods; standards; Product Surveillance, Postmarketing; methods; standards; Th1 Cells; immunology; Th2 Cells; immunology
- From: China Journal of Chinese Materia Medica 2013;38(18):2933-2936
- CountryChina
- Language:Chinese
- Abstract: Through consensus, establish a post-marketing scheme and the technical processes to evaluate Chinese medicine's immunotoxicity on a population, as well as its beneficial influences on the immune system. Provide regulations on the collection, storage and transportation of serum samples. This article applies to the post-marketing scientific evaluation of the immunotoxicity of parenterally administered, and for other ways of taking Chinese medicine.
